Program Locator
| |
Ampyra - approved in 2013.
(Extended Release Pill)
"the
only prescription medicine indicated to help improve walking in adults
with MS. This was demonstrated by an increase in walking speed"
| http://ampyra.com/events/
|
Aubagio -by: Sanofi Genzyme, approved in 2012.
(A once a day oral pill)
"Is approved by FDA to treat relapsing forms of MS."
| www.aubagio.com/events
|
Avonex -by: Avonex,approved in 1996.
(A once a week injection-intramuscular)
"Is approved by FDA to treat relapsing forms of MS."
| www.avonex.com/en_us/home/additional-support/ms-events.html
|
Gilenya by: Norvartis, approved in 2010.
(A once a day oral pill)
"Is a prescription medication use to treat relapsing forms of MS."
| www.gilenya.com/c/living-with-ms/events
|
Lemtrada by: Genzyme, approved in 2014.
(First Treatment: 12 mg/day on 5 consecutive days (60 mg total
dose). Second Treatment: 12 mg/day on 3 consecutive days
(36 mg total dose) administered 12months after the first treatment
course.)
"is a prescription medicine used to treat adults with relapsing
forms of multiple sclerosis (MS). Because of its risks, LEMTRADA is
generally used in people who have tried 2 or more MS medicines that have
not worked well enough." | www.lemtrada.com/events
|
Mallinckrodt (formerly Questcor)
(injection-subcutaneously or inner muscular)
"Acthar is a self-injection. This gives you the flexibility to inject
it at home and on your own schedule—wherever and whenever is best"
| www.msrelapseprograms.com/
|
Mavenclad by: EMD Serono, approved in 2019
(oral medication that is given in only two annual courses for a maximum
of 20 days over a period of two years. No additional treatments are
needed for the next two years) | www.mavenclad.com/en/events#page=1&startDate=2019-04-24&endDate=2019-05-31 |
Mayzent by: Narvartis approved in 2019
(A once a day pill)
"used to treat relapsing forms
of multiple sclerosis, to include clinically isolated syndrome,
relapsing-remitting disease, and active secondary progressive disease,
in adults"
| https://amomentwithmayzent.com/
|
MS
ActiveSource
Multiple drug company programs | www.msactivesource.com/ms-events.xml |
Ocrevus by: Genentech, approved in 2017.
(The first dose is given as 2 separate infusions, 2 weeks apart. Every dose after your first will be given as 1 single infusion 6 months apart)
"Is approved by the FDA to treat relapsing and primary progressive forms of MS." | www.ocrevusevents.com/10312017/#/
|
Plegridy by: Biogen Idec, approved in 2014.
(A bi-weekly injection-subcutaneously)
"Is approved by FDA to treat the long-term treatment of relapsing forms of MS." | www.plegridy.com/support/events |
Rebif - (MS Life Lines) by: EMD Serono, approved in 2002.
(A three day per week injection-subcutaneously)
"Is a prescription medication use to treat relapsing forms of MS." |
www.mslifelines.com/ms-support/ms-live-events
|
Tecfidera by: Biogen Idec, approved in 2013.
(A daily oral pill)
"approved by the FDA for the treatment of people with relapsing forms of MS"
| www.tecfidera.com/en_us/home/additional-support/events.html
|
TYSABRI by: Biogen Idec, approved in 2006.
(A infusion (IV) therapy given once every four weeks)
"Is a prescription medication approved for adult patients with relapsing forms of MS."
| www.tysabri.com/en_us/home/support/events.html
|
Event Locator
| |
MSAA Calendar of Events
| http://support.mymsaa.org/site/PageServer?pagename=Calendar_of_Events |
AboveMS
"To
find an MS event from Biogen in your area, please select the type of
event you are looking for and select a state (if applicable).Be sure to
talk to your doctor as he or she is your main source of information" | www.abovems.com/en_us/home/resources/ms-events/ms-events-webinars.html |
Nancy Davis Foundation
Race to Erase MS Gala & symposium
| www.erasems.org/events/
www.erasems.org/ |
NMSS
Locate: Events, Fundraising, Symposiums & Galas
| Events & Fundraising:
www.nationalmssociety.org/Search?q=events&stype=0&chap=0
Symposiums:
www.nationalmssociety.org/Search?q=symposium&stype=0&chap=0
Galas:
www.nationalmssociety.org/Search?q=gala&stype=0&chap=0
|